Articles

10.4244/EIJV9I4A69 Aug 23, 2013
Antithrombotic therapy in PCI: why not heparin?
Shahzad A, Cooper R, Stables R
free

10.4244/EIJV9I4A70 Aug 23, 2013
More than ever, a true need to work together: Stent for Life
Fajadet J
free

10.4244/EIJV9I4A71 Aug 23, 2013
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial
Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier K, Laugwitz K, Kufner S, Gick M, Dommasch M, Schühlen H, Schömig A, Berger P, Mehilli J, Neumann F
free

10.4244/EIJV9I4A72 Aug 23, 2013
Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2
Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T
free

10.4244/EIJV9I4A73 Aug 23, 2013
Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery
Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H
free

10.4244/EIJV9I4A74 Aug 23, 2013
Two-year outcomes of everolimus vs. paclitaxel-eluting stent for the treatment of unprotected left main lesions: a propensity score matching comparison of patients included in the French Left Main Taxus (FLM Taxus) and the LEft MAin Xience (LEMAX) registries
Moynagh A, Salvatella N, Harb T, Darremont O, Boudou N, Dumonteil N, Lefèvre T, Carrié D, Louvard Y, Leymarie J-L, Chevalier B, Morice M, Garot P
free

10.4244/EIJV9I4A75 Aug 23, 2013
New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN® device in patients not taking warfarin
Meincke F, Schmidt-Salzmann M, Kreidel F, Kuck K, Bergmann M
free

10.4244/EIJV9I4A76 Aug 23, 2013
Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation
Laut K, Gale C, Pedersen A, Fox K, Lash T, Kristensen SD
free

10.4244/EIJV9I4A77 Aug 23, 2013
Implementation of a physician-staffed helicopter: impact on time to primary PCI
Hesselfeldt R, Pedersen F, Steinmetz J, Vestergaard L, Simonsen L, Jørgensen E, Clemmensen P, Rasmussen L
free

10.4244/EIJV9I4A78 Aug 23, 2013
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry
Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe U, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump L, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G
free

10.4244/EIJV9I4A80 Aug 23, 2013
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI)
Kajiya T, Liang M, Sharma R, Lee C-H, Chan M, Tay E, Chan K-H, Tan H-C, Low A
free

10.4244/EIJV9I4A81 Aug 23, 2013
First-in-man intracoronary use of the Trevo® Pro 4 mechanical thrombectomy device for the retrieval of large intracoronary thrombus in patients with acute coronary syndromes
van de Hoef TP, Woudstra P, Sprengers M, Koch K, Majoie C, Piek J, de Winter R
free

10.4244/EIJV9I3A48 Jul 26, 2013
The Journal Citation Reports® Impact Factor: annual results 2012
Cummins P, Serruys PW
free
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved